Breast implants slightly increase risk of breast ALCL

January 5, 2018

(HealthDay)—Breast implants are associated with an increased risk of anaplastic large-cell lymphoma in the breast (breast-ALCL), though the absolute risk is small, according to a study published online Jan. 4 in JAMA Oncology.

Mintsje de Boer, M.D., from the Maastricht University Medical Centre in the Netherlands, and colleagues used data from the nationwide Dutch pathology registry to identify all patients diagnosed with primary non-Hodgkin in the breast between 1990 and 2016. In addition, clinical data, including breast implant status, were obtained from treating physicians. The authors used a case-control design to compare prevalence between women with breast-ALCL and those with other types of breast lymphoma.

The researchers found that 32 of the 43 patients with breast-ALCL (median age, 59 years) had ipsilateral breast implants, compared with one case among 146 women with other primary breast lymphomas (odds ratio, 421.8). Among breast-ALCL cases, implants were more often macrotextured (23 macrotextured of 28 total implants of known type; 82 percent) compared to what might be expected based on sales data (45 percent). The cumulative risks of breast-ALCL in women with implants were 29 per million at 50 years old and 82 per million at 70 years old. To cause one breast-ALCL case before age 75 years, the number of women with implants needed was 6,920.

"Our results emphasize the need for increased awareness among the public, medical professionals, and regulatory bodies; promotion of alternative cosmetic procedures; and alertness to signs and symptoms of breast-ALCL in women with implants," the authors write.

Explore further: Rare cancer linked with textured breast implants may be underreported, misunderstood

More information: Abstract/Full Text
Editorial

Related Stories

Rare cancer linked with textured breast implants may be underreported, misunderstood

October 18, 2017
A rare cancer in patients with breast implants may be on the rise, but not all patients and physicians may be aware of the risks associated with the procedure, according to a group of Penn State College of Medicine researchers.

Nine US deaths linked to breast implant-associated cancer

March 22, 2017
Nine women are believed to have died in the United States from a rare cancer linked to breast implants, US health officials said Tuesday, with more than 350 cases of the disease recorded nationwide.

Link between breast implants and cancer under investigation

October 6, 2014
An international research group including Viennese pathologist Lukas Kenner has reviewed cases of possible association between breast implants and a form of lymphoma that may develop tumors at a later stage. The researchers ...

Implant-lymphoma link underscores importance of breast device registry

August 25, 2017
A paper published in the Medical Journal of Australia, involving Monash University researchers, stresses the importance of long-term post market surveillance of breast implants by a clinical quality registry as essential ...

Study offers clues to how breast implants may cause lymphoma

September 17, 2014
(Medical Xpress)—There have been 71 known cases worldwide of a type of blood cancer called anaplastic large cell lymphoma (ALCL) that the researchers suggest were associated with the patient's breast implants. This means ...

Complete surgical excision is the most effective treatment for breast implant-associated anaplastic large-cell lymphoma

December 1, 2015
The optimal treatment approach for most women with breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is complete surgical excision of the implant and surrounding capsule, according to an international study ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

Overcoming resistance to a standard chemotherapy drug

July 19, 2018
Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.